Introduction

64
SOCS were first discovered as inhibitors of the Janus kinase/signal 65 transducer of activation pathway [7, 8] ; however they are increas-66 ingly thought to control other pathways, such as the focal adhesion 67 kinase (FAK) signalling pathway [9] [10] [11] created from the raw data in microsoft excel. Groups were then 160 compared using Student's t-test for statistical significance 161 ( * P 6 0.05, ** P 6 0.01 and *** P 6 0.001). noblotting (data not shown). SOCS2 had no effect on CCL11-in-172 duced migration, but both SOCS1 and 3 significantly reduced cell 173 mobility (Fig. 1A) . Having identified SOCS1 and 3 as potent inhib- between 30 and 60 min. SOCS1 expressing cell also adhered signif- Fig. 1 . SOCS1 and 3 regulate migration towards CCL11. HEK293T cells were transfected with 5 lg of CCR3 and SOCS1-3 constructs, before chemotaxis using 100 ng/ml CCL11 (A). Chemotaxis was also analysed using SOCS1 and 3 null and stable and WT MEFs towards CCL11 (5 ng/ml) (B-D). Data are mean ± S.E.M. (n = 3). SOCS1 and 3 expression was confirmed by immunoblotting (E) (n = 3). Migration of WT and SOCS3 null BMDMs towards CCL11 (5 ng/ml) was measured (F). (Fig. 3A and B) . However, protein and tyrosine phosphoryla-212 tion were upregulated by CCL11 stimulation (Fig. 3A and B) . In 213 contrast, constitutive FAK expression and phosphorylation were 214 enhanced in both SOCS1 and 3 expressing MEFs (Fig. 3A and B) .
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WT MEFs expressed low levels of FAK and low endogenous FAK 216 phosphorylation was enhanced upon CCL11 treatment (Fig. 3C ).
217
To further investigate FAK phosphorylation, we analysed pFAK by 218 confocal microscopy in WT, stable and null SOCS1 and 3 MEFs. SOCS1À/ÀIFN-cÀ/À mice [20] . This phenotype was thought to be promote its degradation and thus reduce migration to fibronectin 268 [10, 11, 21] . In contrast, we discovered enhanced expression and 269 tyrosine phosphorylation of FAK in the presence of SOCS1 or 3. 270 We went on to find that these cells, with enhanced pFAK were analysed in WT, SOCS1 and 3 null and stable cells by confocal microscopy (D). b1 Integrin levels were analysed by Western blotting lysates from WT, SOCS1 and 3 null and stable MEFs stimulated for 0, 30 and 60 min with CCL11 (100 ng/ml) (E). SOCS1 and 3 stable and null MEFs were treated with CCL11 (100 ng/ml) for 0, 5 and 15 min and the activation of RhoA assessed by pull down assay using GST-Rhotekin. Proteins extracted by pull down and whole cell lysates were immunoblotted with anti-RhoA antibody (F). 
